Crescent Biopharma, Inc.
CBIO
$14.47
-$0.23-1.57%
NASDAQ
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 152.65M | 22.43M | |||
| Total Receivables | -- | -- | |||
| Inventory | -- | -- | |||
| Prepaid Expenses | 1.58M | 409.00K | |||
| Finance Division Loans and Leases Current | -- | -- | |||
| Total Finance Division Other Current Assets | -- | -- | |||
| Other Current Assets | -- | -- | |||
| Total Current Assets | 154.23M | 22.84M | |||
|
|
|||||
| Total Current Assets | 154.23M | 22.84M | |||
| Net Property, Plant & Equipment | 1.80M | -- | |||
| Long-term Investments | -- | -- | |||
| Goodwill | -- | -- | |||
| Total Other Intangibles | -- | -- | |||
| Finance Div Loans & Leases LT | -- | -- | |||
| Total Finance Div Other LT Assets | -- | -- | |||
| Total Other Assets | 1.41M | 2.77M | |||
| Total Assets | 157.43M | 25.61M | |||
|
|
|||||
| Total Accounts Payable | 1.65M | 634.00K | |||
| Total Accrued Expenses | 12.79M | 12.78M | |||
| Short-term Debt | -- | -- | |||
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | |||
| Finance Division Debt Current | 211.00K | -- | |||
| Total Finance Division Other Current Liabilities | 2.10M | 874.00K | |||
| Total Other Current Liabilities | 2.10M | 874.00K | |||
| Total Current Liabilities | 16.75M | 14.28M | |||
|
|
|||||
| Total Current Liabilities | 16.75M | 14.28M | |||
| Long-Term Debt | -- | 37.48M | |||
| Short-term Debt | -- | -- | |||
| Capital Leases | 1.43M | -- | |||
| Finance Division Debt Non Current | -- | -- | |||
| Total Finance Division Other Non Current Liabilities | -- | -- | |||
| Total Other Liabilities | -- | -- | |||
| Total Liabilities | 18.18M | 51.77M | |||
|
|
|||||
| Common Stock & APIC | 194.06M | 2.85M | |||
| Retained Earnings | -54.81M | -33.02M | |||
| Treasury Stock & Other | -- | -- | |||
| Total Common Equity | 139.25M | -30.16M | |||
|
|
|||||
| Preferred Stock Redeemable | -- | -- | |||
| Preferred Stock Non Redeemable | -- | -- | |||
| Preferred Stock Convertible | -- | 4.00M | |||
| Preferred Stock, Others | -- | -- | |||
| Total Preferred Equity | -- | 4.00M | |||
|
|
|||||
| Total Common Equity | 139.25M | -30.16M | |||
| Total Preferred Equity | -- | 4.00M | |||
| Total Minority Interest | -- | -- | |||
| Total Equity | 139.25M | -26.16M | |||
|
|
|||||